We first analyzed the expression of several key m6A regulatory genes in GSE77298, and the results demonstrated that IGF2BP3 was upregulated in patients with RA, which was further confirmed in TNF-α and IL-1β-treated MH7A cells. The gene discussed is TNF; the disease is rheumatoid arthritis.